No Data
No Data
IX Biopharma Issues 1.7 Million New Shares Under Performance Plan
IX Biopharma Proposes Appointment of BDO LLP as New Auditors
IX Biopharma Loss Narrows in H2 2024
Financial Statements and Related Announcement-Half Yearly Results
IX Biopharma Discloses Result of IXB 401 Preclinical Study
IX Biopharma's IXB 401: A Breakthrough in Drug Delivery
hh488 : They trying to release some positive news prior to the payment of the rights. So don't get caught & jump in right away!